Target intelligence / Profile preview

Lipid transfer protein anchored at membrane contact sites 4, StARkin domain 2 (Lam4S2) (Lam4S2)

Target
Lam4S2
Molecular classification
Lipid transfer protein, StARkin domain protein, GRAM domain-containing protein
01

Overview

Lam4S2 is the second StARkin (also known as StART-like) domain of the yeast protein Lipid transfer protein anchored at membrane contact sites 4 (Lam4, or Ltc3), which belongs to the LAM/Ltc family of lipid transfer proteins. This domain is specialized for the non-vesicular transport of sterols between the endoplasmic reticulum and the plasma membrane at specific membrane contact sites [1, 2]. Structurally, it features a characteristic "helix-grip" fold that creates a deep hydrophobic pocket tailored to accommodate sterol molecules like ergosterol and cholesterol [1, 10]. Functionally, Lam4S2 acts as a lipid transporter by extracting sterols from a donor membrane and delivering them to an acceptor membrane, thereby maintaining cellular sterol distribution and membrane homeostasis [5, 11]. In yeast, the loss of Lam4 and its paralogs results in increased sensitivity to polyene antifungal drugs such as amphotericin B and nystatin, identifying these proteins as potential targets for therapeutic sensitization [2, 5]. Furthermore, Lam4S2 serves as a key model for its human orthologs, the GRAMD1 (Aster) proteins, which are implicated in cholesterol-related metabolic disorders and cancer progression [1, 8, 11].

Other names
Ltc3 StARkin domain 2Yhr080c StARkin domain 2StARkin domain 2 of Lam4StART-like domain-containing protein 3, domain 2Ltc3 SD2
02

Mechanism of action

Facilitates non-vesicular lipid transport by extracting sterol molecules into a hydrophobic pocket and transferring them between membranes at contact sites [1, 12].

03

Biological functions

Non-vesicular sterol transportSterol homeostasisLipid sensingEndoplasmic reticulum-plasma membrane tethering
04

Disease associations

Fungal infectionAntifungal resistanceMetabolic disorder (via human orthologs)Cancer (via human orthologs)
05

Safety considerations

Potential for off-target effects on human orthologs (GRAMD1/Aster proteins)Disruption of essential membrane homeostasis and signaling pathways such as TORC2 [11]
06

Interacting drugs

Amphotericin B

4 more in the full profile.

07

Biomarkers

Sensitivity to polyene antifungals

Beyond the preview

Go deeper on Lipid transfer protein anchored at membrane contact sites 4, StARkin domain 2 (Lam4S2) (Lam4S2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid transfer protein anchored at membrane contact sites 4, StARkin domain 2 (Lam4S2) (Lam4S2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call